New medicines typically cost hundreds of millions of dollars, requiring over a decade to develop. Repurposing existing medicines may rapidly provide safe, effective, affordable therapies to treat and prevent cardiovascular events. Dr Sonali Gnanenthiran's project encompasses a series of studies that assess new uses for old medicines already on the market or new combinations of medicines to reduce cardiovascular events.
The research involves testing:
(i) an anti-inflammatory drug as a new blood thinner in elderly people;
(ii) a blood pressure lowering medicine in patients with coronavirus disease 2019 (COVID-19) to improve health outcomes;
(iii) a new single pill of several medicines (‘polypill’) including a blood thinner, cholesterol lowering drug and an anti-inflammatory to prevent recurrent heart attacks;
(iv) a new polypill to treat heart failure by improving compliance to recommended medicines.
Repurposing well-tolerated commonly used drugs offers an innovative, cost-effective and practical strategy to improve health outcomes in high-risk patients.
Last updated30 March 2022